TP53 and oculopharyngeal muscular dystrophy: Furthermore, for high-risk OPMD lesions, p53 immunoreactivity may be recommended for predicting the probable malignant potential of OPMDs, which will therefore improve the prognosis of OSCC by intercepting the disease in the preclinical cancerous stage.